News

A Growing Double BurdenThe rising prevalence of prediabetes and chronic kidney disease (CKD) in India reflects an ...
A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...
Lembas is a new b2b ingredient business that makes a peptide powder that targets the GLP-1 hormone for weight loss ...
Coming off a successful initial public offering, Omada Health President Wei-Li Shao said the company is focused on turning a ...
GLP-1 drugs “alter taste perception” and "disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...
Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link ...
Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...
MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...